Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gines Diego Miralles currently holds 232,500 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $0. This represents their equity stake as President & Head of R&D.
Based on SEC Form 4 filings, Gines Diego Miralles has been a net neutral trader of ARTV stock. They have purchased $0 and sold $0 worth of shares.
Gines Diego Miralles's most recent insider trade was on May 18, 2026, when they sold 232,500 shares at $0.00 per share.
Gines Diego Miralles serves as President & Head of R&D at Artiva Biotherapeutics, Inc. (ARTV). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Gines Diego Miralles holds the position of President & Head of R&D at Artiva Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Gines Diego Miralles has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gines Diego Miralles was on May 18, 2026, when they purchased $0 worth of ARTV shares. This transaction involved 232,500 shares at N/A per share.
Gines Diego Miralles currently owns 232,500 shares of Artiva Biotherapeutics, Inc. (ARTV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gines Diego Miralles's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gines Diego Miralles has 2 Form 4 filings on record as an insider at Artiva Biotherapeutics, Inc..
Set alerts for Gines Diego Miralles and 40,000+ other insiders.